From September 2020, UNYP will be subscribing to the Perlego textbook platform. This partnership between UNYP and Perlego provides unlimited free digital textbooks to students that allows everyone to continue learning safely anywhere and at any time. Students and faculty will have free access to over 300k book titles, with the goal of 100% access to diverse course readings for graduate and undergraduate programs. 

Since Pfizer and our collaboration partner, BioNTech, begun our mission to develop a COVID-19 vaccine, safety has been our guiding principle every step of the way. At the same time, given the urgency of the global pandemic, we continue to move at record-breaking speed. We recently started the phase 2/3 safety and efficacy trial for our lead vaccine candidate, approximately three months after we started the phase 1/2 safety and immunogenicity trials in Germany and the United States for our four initial vaccine candidates.  Progressing from the start of clinical testing for a vaccine candidate in small numbers of trial participants to a large-scale efficacy trial is a process that can usually take years, sometimes even a decade.